Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I BERGER

Showing results (341-350 of 406) with videos related to

Pageof 41
Sort By:
Cancer Research|June 30, 2001
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomasM S Wiesener, P M Münchenhagen, I Berger, et al.
Journal of Inherited Metabolic Disease|August 25, 2016
Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndromeChristian J Hendriksz, Kenneth I Berger, Rossella Parini, et al.
European Journal of Internal Medicine|June 15, 2016
Unique medical issues in adult patients with mucopolysaccharidosesJohn Mitchell, Kenneth I Berger, Andrea Borgo, et al.
Human Genetics|February 19, 2017
Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variantsSeth I Berger, Carla Ciccone, Karen L Simon, et al.
Ear and Hearing|May 5, 2023
Neural Correlates of Individual Differences in Speech-in-Noise Performance in a Large Cohort of Cochlear Implant UsersJoel I Berger, Phillip E Gander, Subong Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Identification of <i>de novo</i> variants from parent-proband duos via long-read sequencingLeandros Boukas, Emmanuèle C Délot, Georgia Pitsava, et al.
The Journal of Pediatrics|May 6, 2004
Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)James E Wraith, Lorne A Clarke, Michael Beck, et al.
American Journal of Medical Genetics. Part A|June 13, 2015
Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot studyBarbara K Burton, Kenneth I Berger, Gregory D Lewis, et al.
Journal of Occupational and Environmental Medicine|August 24, 2011
Lung pathologic findings in a local residential and working community exposed to World Trade Center dust, gas, and fumesCaralee E Caplan-Shaw, Herman Yee, Linda Rogers, et al.
American Journal of Medical Genetics. Part A|February 4, 2005
Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)Stuart J Swiedler, Michael Beck, Manal Bajbouj, et al.
Pageof 41

Showing results (341-350 of 406) with videos related to

Sort By:
Pageof 41
Cancer Research|June 30, 2001
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomasM S Wiesener, P M Münchenhagen, I Berger, et al.
Journal of Inherited Metabolic Disease|August 25, 2016
Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndromeChristian J Hendriksz, Kenneth I Berger, Rossella Parini, et al.
European Journal of Internal Medicine|June 15, 2016
Unique medical issues in adult patients with mucopolysaccharidosesJohn Mitchell, Kenneth I Berger, Andrea Borgo, et al.
Human Genetics|February 19, 2017
Exome analysis of Smith-Magenis-like syndrome cohort identifies de novo likely pathogenic variantsSeth I Berger, Carla Ciccone, Karen L Simon, et al.
Ear and Hearing|May 5, 2023
Neural Correlates of Individual Differences in Speech-in-Noise Performance in a Large Cohort of Cochlear Implant UsersJoel I Berger, Phillip E Gander, Subong Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Identification of <i>de novo</i> variants from parent-proband duos via long-read sequencingLeandros Boukas, Emmanuèle C Délot, Georgia Pitsava, et al.
The Journal of Pediatrics|May 6, 2004
Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)James E Wraith, Lorne A Clarke, Michael Beck, et al.
American Journal of Medical Genetics. Part A|June 13, 2015
Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot studyBarbara K Burton, Kenneth I Berger, Gregory D Lewis, et al.
Journal of Occupational and Environmental Medicine|August 24, 2011
Lung pathologic findings in a local residential and working community exposed to World Trade Center dust, gas, and fumesCaralee E Caplan-Shaw, Herman Yee, Linda Rogers, et al.
American Journal of Medical Genetics. Part A|February 4, 2005
Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)Stuart J Swiedler, Michael Beck, Manal Bajbouj, et al.
Pageof 41